Avidity Biosciences, Inc. — Director's Dealing 2024

Sep 11, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2024-09-06

Reporting Person: LEVIN ARTHUR A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-06	Common Stock	G	22500	—	Disposed	131372	Indirect
2024-09-06	Common Stock	G	22500	—	Acquired	22500	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	14830	Direct